Sutro Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	73.68	58.13	190.3	69.27	47.25	30.41
Short-Term Investments	128.88	83.3	126.59	306.35	287.11	167.52
Cash & Short-Term Investments	202.56	141.43	316.9	375.62	334.36	197.94
Cash Growth	-18.64%	-55.37%	-15.63%	12.34%	68.92%	-46.23%
Accounts Receivable	12.48	3.98	8.62	36.08	7.12	12.45
Other Current Assets	5.93	5.52	17.8	9.85	11.67	8.12
Total Current Assets	220.97	150.93	343.31	421.54	353.15	218.52
Net Property, Plant & Equipment	19.07	21.55	35.87	44.76	51.06	51.59
Long-Term Investments	-	-	-	-	-	68.78
Other Long-Term Assets	1.95	1.35	8.03	4.44	2.73	2.53
Total Assets	241.99	173.83	387.21	470.74	406.94	341.41
Accounts Payable	5.49	7.57	10.48	9.44	4.8	6.01
Accrued Expenses	48.33	49.22	44.16	53.16	27.91	19.82
Current Portion of Long-Term Debt	-	-	-	4.06	12.5	9.38
Current Portion of Leases	7.6	7.78	7.48	6.42	4.59	1.04
Unearned Revenue	9.4	10.56	69.78	20.67	16.76	5.5
Total Current Liabilities	70.81	75.13	131.89	93.75	66.55	41.74
Long-Term Debt	-	-	-	-	3.77	15.74
Long-Term Leases	6.03	7.89	15.67	23.15	29.57	31.22
Other Long-Term Liabilities	232.03	223.26	195.04	204.19	90	0.15
Total Long-Term Liabilities	238.06	231.15	210.71	227.34	123.35	47.11
Total Liabilities	308.88	306.28	342.61	321.09	189.9	88.84
Common Stock	0.02	0.01	0.01	0.06	0.06	0.05
Additional Paid-in Capital	949.64	845.48	831.42	708.98	670.22	586.24
Accumulated Other Comprehensive Income	-0.1	0.02	0.04	0.02	-0.62	-0.31
Retained Earnings	-1,016	-977.96	-786.87	-559.41	-452.62	-333.41
Shareholders' Equity	-66.89	-132.45	44.6	149.65	217.05	252.56
Total Liabilities & Equity	241.99	173.83	387.21	470.74	406.94	341.41
Total Debt	13.63	15.67	23.15	33.64	50.43	57.37
Net Cash (Debt)	188.93	125.75	293.74	341.98	283.93	140.56
Net Cash Growth	50.23%	-57.19%	-14.11%	20.45%	102.00%	-59.09%
Net Cash Per Share	19.50	14.80	37.97	56.84	55.96	30.48
Book Value	-66.89	-132.45	44.6	149.65	217.05	252.56
Book Value Per Share	-6.90	-15.59	5.76	24.87	42.78	54.76
Tangible Book Value	-66.89	-132.45	44.6	149.65	217.05	252.56
Tangible Book Value Per Share	-6.90	-15.59	5.76	24.87	42.78	54.76

SEC Filings: 10-K · 10-Q